Metformin in COVID-19: A possible role beyond diabetes
Volume: 164, Pages: 108183 - 108183
Published: Jun 1, 2020
Abstract
It is a lesser-known fact that metformin was originally introduced as an anti-influenza drug and that glucose-lowering was only one of its side effects [[1]Amin S. Lux A. O’Callaghan F. The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth.Br J Clin Pharmacol. 2019; 85: 37-46https://doi.org/10.1111/bcp.13780Crossref PubMed Scopus (65) Google Scholar]. The many pleiotropic effects of metformin and...
Paper Details
Title
Metformin in COVID-19: A possible role beyond diabetes
Published Date
Jun 1, 2020
Volume
164
Pages
108183 - 108183
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History